Melanoma Institute Australia   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Wollstonecraft Australia (1982)

Organization Overview

First Clinical Trial
2007
NCT00521053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Melanoma Institute Australia | Sydney Melanoma Unit